Delaware court dismisses Merck's talc liability suit against Bayer
A chancery court judge in Delaware has sided with Bayer, dismissing a case between two pharma giants over liabilities from a 2014 M&A deal.
Delaware chancery court vice chancellor Nathan Cook signed off on Bayer’s motion to dismiss the case Monday. The chancery court previously held a hearing in December on Bayer’s motion, the ruling said.
This case got its beginnings after Merck and Bayer entered into a contract for Bayer to buy Merck’s consumer care business in 2014. The $14 billion deal included the product lines for Dr. Scholl’s, along with Claritin allergy medicine and Coppertone sunscreen. Merck claimed that as part of its contract with Bayer, Merck would remain liable for certain product claims for only seven years — and hand liabilities over to Bayer on Oct. 1, 2021.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.